Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 1576 AL 1590

Reperfusion therapies for ischemic stroke in dementia and cognitive impairment: A systematic review and meta-analysis

Bala F, Betzner W, Beland B, McDonald JS, Ganesh A.

Int J Stroke. 2024 Oct;19(8):867-875. doi: 10.1177/17474930231220186. Epub 2023 Dec 27.

Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia

Hainsworth AH, Markus HS, Schneider JA.

Hypertension. 2024 Jan;81(1):75-86. doi: 10.1161/HYPERTENSIONAHA.123.19943. Epub 2023 Nov 29.

An Online Shared Decision-making Intervention for Dementia Prevention: A Parallel-group Randomized Pilot Study

Ownby RL, Davenport R.

Curr Alzheimer Res. 2023;20(8):577-587. doi: 10.2174/0115672050274126231120112158.

Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial

Saito S, Suzuki K, Ohtani R, Maki T, Kowa H, Tachibana H, Washida K, Kawabata N, Mizuno T, Kanki R, Sudoh S, Kitaguchi H, Shindo K, Shindo A, Oka N, Yamamoto K, Yasuno F, Kakuta C, Kakuta R, Yamamoto Y, Hattori Y, Takahashi Y, Nakaoku Y, Tonomura S, Oishi N, Aso T, Taguchi A, Kagimura T, Kojima S, Taketsuna M, Tomimoto H, Takahashi R, Fukuyama H, Nagatsuka K, Yamamoto H, Fukushima M, Ihara M; COMCID Trial Investigator Group.

JAMA Netw Open. 2023 Dec 1;6(12):e2344938. doi: 10.1001/jamanetworkopen.2023.44938.

Increased risk of osteoporosis in patients with cognitive impairment: a systematic review and meta-analysis

Xie C, Wang C, Luo H.

BMC Geriatr. 2023 Dec 4;23(1):797. doi: 10.1186/s12877-023-04548-z.

Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden

Lyon M, Fullerton JL, Kennedy S, Work LM.

Pharmacol Ther. 2024 Jan;253:108575. doi: 10.1016/j.pharmthera.2023.108575. Epub 2023 Dec 3.

Risk assessment for people living with dementia: a systematic review

Hoe J, Profyri E, Kemp C, Manela M, Webster L, Anthony J, Costafreda S, Arrojo F, Souris H, Livingston G.

Int Psychogeriatr. 2024 Apr;36(4):263-288. doi: 10.1017/S1041610223004398. Epub 2023 Dec 6.

Transcranial direct current stimulation of the right temporoparietal junction facilitates hippocampal spatial learning in Alzheimer's disease and mild cognitive impairment

Philippen S, Hanert A, Schönfeld R, Granert O, Yilmaz R, Jensen-Kondering U, Splittgerber M, Moliadze V, Siniatchkin M, Berg D, Bartsch T.

Clin Neurophysiol. 2024 Jan;157:48-60. doi: 10.1016/j.clinph.2023.11.003. Epub 2023 Nov 15.

Beyond cardiovascular risk: Implications of Familial hypercholesterolemia on cognition and brain function

de Oliveira J, Moreira ELG, de Bem AF.

Ageing Res Rev. 2024 Jan;93:102149. doi: 10.1016/j.arr.2023.102149. Epub 2023 Dec 4.

Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment

Taylor-Rowan M, Alharthi AA, Noel-Storr AH, Myint PK, Stewart C, McCleery J, Quinn TJ.

Cochrane Database Syst Rev. 2023 Dec 8;12(12):CD015405. doi: 10.1002/14651858.CD015405.pub2.

LETHE: A Digital Intervention for Cognitive Decline

Loukas VS, Kassiotis T, Martinez IL, Koumakis L, Bruinsma J, Pasciuti R, Balatresi M, Tenhunen V, Fiakkas A, Ataliani L, Karanasiou GS, Tsiknakis M, Hilberger H, Bodenler M, Schnalzer B, Huber S, Pirani M, Colombo M, Hanke S, Fotiadis DI.

Annu Int Conf IEEE Eng Med Biol Soc. 2023 Jul;2023:1-4. doi: 10.1109/EMBC40787.2023.10340897.

NeuroEPO plus (NeuralCIM(®)) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial

Sosa S, Bringas G, Urrutia N, Peñalver AI, López D, González E, Fernández A, Hernández ZM, Viña A, Peña Y, Batista JF, Valenzuela C, León K, Crombet T, Rodríguez T, Pérez L; ATHENEA Investigators.

Alzheimers Res Ther. 2023 Dec 13;15(1):215. doi: 10.1186/s13195-023-01356-w.

Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial

Schlosser M, Demnitz-King H, Barnhofer T, Collette F, Gonneaud J, Chételat G, Jessen F, Kliegel M, Klimecki OM, Lutz A, Marchant NL; Medit-Ageing Research Group.

PLoS One. 2023 Dec 15;18(12):e0295175. doi: 10.1371/journal.pone.0295175. eCollection 2023.

Efficacy of scalp stimulation for multidomain cognitive impairment in patients with post-stroke cognitive impairment and dementia: A network meta-analysis and meta-regression of moderators

Xu M, Li Y, Zhang C, Ma Y, Zhang L, Yang Y, Zhang Z, Meng T, He J, Wang H, Li S, Kranz GS, Zhao M, Chang J.

J Evid Based Med. 2023 Dec;16(4):505-519. doi: 10.1111/jebm.12568. Epub 2023 Dec 15.

A deep learning model for the detection of various dementia and MCI pathologies based on resting-state electroencephalography data: A retrospective multicentre study

Watanabe Y, Miyazaki Y, Hata M, Fukuma R, Aoki Y, Kazui H, Araki T, Taomoto D, Satake Y, Suehiro T, Sato S, Kanemoto H, Yoshiyama K, Ishii R, Harada T, Kishima H, Ikeda M, Yanagisawa T.

Neural Netw. 2024 Mar;171:242-250. doi: 10.1016/j.neunet.2023.12.009. Epub 2023 Dec 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias